Skip to content
Learning that drives better investment decisions

Duopharma Biotech – World Class Benchmarking

Company: Duopharma Biotech Berhad

Bloomberg ticker: DDB MK

Market cap: US$245m

Background: Duopharma Biotech Berhad is an investment holding company, engaged in the research, development, and commercialization of chemical and pharmaceutical products. The company’s products include tablets, capsules, syrup, antibiotics, creams, sterile powder injectables, small volume injectables, dental cartridges, and eye drop preparations.

World Class Benchmarking of Duopharma Biotech



 

  • Profitable Growth rank of 3 was same compared to the prior period’s 3rd rank
  • This is above average performance compared to 720 small Health Care companies worldwide
  • Profitability rank of 3 was better than its Growth rank of 4
  • Profitability rank of 3 was the same compared to the prior period’s 3rd rank
  • This is above average performance compared to peers
  • Growth rank of 4 was the same compared to the prior period’s 4th rank
  • This is above average performance compared to peers

 


DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.